SCHEMBL29972913

SCHEMBL29972913

NC1=CCC(N)(CC2(CN3CCOCC3)COC2)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29973164 0.91
SCHEMBL29973340 0.75 KEAP1 (0.40)
SCHEMBL6692693 0.65 SMN1; SMN2 (0.42)
SCHEMBL23579206 0.65
SCHEMBL17580422 0.63
SCHEMBL20876924 0.62
SCHEMBL23609413 0.62 KDM4E (0.40)
SCHEMBL29974830 0.61 MAPT (0.37)
SCHEMBL30701837 0.61 LMNA (0.35)
SCHEMBL22720027 0.60 KDM4E (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081199-A2 LIPOXYGENASE INHIBITORS SRI International (US) 2022-11-02 EP disclosed